乳腺密度与数字乳腺断层摄影筛查:TOSYMA试验亚组分析
TOSYMA随机对照试验的探索性亚组分析纳入约10万50-69岁女性,比较DBT+合成乳腺摄影与数字乳腺摄影在不同乳腺密度类别中的浸润性癌检出率。结果显示在致密乳腺(尤其是极度致密)中,DBT+SM的浸润性癌检出率高于数字乳腺摄影,极度致密乳腺中数字乳腺摄影的比值比为3.8(95%CI 1.5-11.1)。
要点
- 在极度致密乳腺中,DBT+SM的浸润性癌检出率显著高于数字乳腺摄影。
- 乳腺密度类别C和D中DBT+SM检出率较高,支持致密乳腺使用DBT筛查。
- DBT+SM检出的浸润性癌多为2级肿瘤。
核心结论
- 在致密乳腺中,DBT+SM的浸润性癌检出率高于数字乳腺摄影,相对和绝对差异在极度致密乳腺中最明显。
研究设计与样本
- TOSYMA试验的探索性亚组分析,随机对照多中心平行组设计,2018年7月至2020年12月在德国乳腺摄影筛查项目中招募。
- 共纳入49 762例分配至DBT+SM组和49 796例分配至数字乳腺摄影组,年龄50-69岁,中位年龄57岁(IQR 53-62岁)。
- 乳腺密度按BI-RADS Atlas视觉评估分为A-D四类。
诊断标准与关键数值
- D类乳腺中数字乳腺摄影对比DBT+SM的比值比为3.8(95%CI 1.5-11.1)。
- DBT+SM检出的浸润性癌多为2级肿瘤:C类中占58%(91/156),D类中占47%(15/32)。
临床应用与阅片要点
- 在极度致密乳腺(D类)筛查中,DBT+SM可提高浸润性癌检出率,支持对此类人群使用DBT。
- 报告乳腺密度时应注意其对筛查方法选择的影响,致密乳腺推荐DBT+SM。
局限性
- 本文为探索性亚组分析,非主要终点分析。
- 乳腺密度为视觉评估,可能存在观察者间差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Digital breast tomosynthesis (DBT) plus synthesized mammography (SM) reduces the diagnostic pitfalls of tissue superimposition, which is a limitation of digital mammography (DM). Purpose To compare the invasive breast cancer detection rate (iCDR) of DBT plus SM versus DM screening for different breast density categories. Materials and Methods An exploratory subanalysis of the TOmosynthesis plus SYnthesized MAmmography (TOSYMA) study, a randomized, controlled, multicenter, parallel-group trial recruited within the German mammography screening program from July 2018 to December 2020. Women aged 50-69 years were randomly assigned (1:1) to DBT plus SM or DM screening examination. Breast density categories A-D were visually assessed according to the Breast Imaging Reporting and Data System Atlas. Exploratory analyses were performed of the iCDR in both study arms and stratified by breast density, and odds ratios and 95% CIs were determined. Results A total of 49 762 women allocated to DBT plus SM and 49 796 allocated to DM (median age, 57 years [IQR, 53-62 years]) were included. In the DM arm, the iCDR was 3.6 per 1000 screening examinations in category A (almost entirely fatty) (16 of 4475 screenings), 4.3 in category B (102 of 23 534 screenings), 6.1 in category C (116 of 19 051 screenings), and 2.3 in category D (extremely dense breasts) (six of 2629 screenings). The iCDR in the DBT plus SM arm was 2.7 per 1000 screening examinations in category A (12 of 4439 screenings), 6.9 in category B (154 of 22 328 screenings), 8.3 in category C (156 of 18 772 screenings), and 8.1 in category D (32 of 3940 screenings). The odds ratio for DM versus DBT plus SM in category D was 3.8 (95% CI: 1.5, 11.1). The invasive cancers detected with DBT plus SM were most often grade 2 tumors; in category C, it was 58% (91 of 156 invasive cancers), and in category D, it was 47% (15 of 32 invasive cancers). Conclusion The TOmosynthesis plus SYnthesized MAmmography trial revealed higher invasive cancer detection rates with digital breast tomosynthesis plus synthesized mammography than digital mammography in dense breasts, relatively and absolutely most marked among women with extremely dense breasts. ClinicalTrials.gov registration no.: NCT03377036 © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Lee and Moy in this issue.
引用
- Weigel, Heindel, Hense, et al. Breast Density and Breast Cancer Screening with Digital Breast Tomosynthesis: A TOSYMA Trial Subanalysis. Radiology. 2022. PMID: 36194110. doi:10.1148/radiol.221006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。